Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase

References

• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2019. CA Cancer J Clin. 2019;64:9–29. doi:10.3322/caac.21208
   Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. doi:10.1158/0008-5472.CAN-14-015524840647
   PubMed Web of Science ®Google Scholar
• Wu H, Chen X, Ji J, et al. Progress of exosomes in the diagnosis and treatment of pancreatic cancer. Genet Test Mol Biomarkers. 2019;23(3):215–222. doi:10.1089/gtmb.2018.023530793953
   PubMed Web of Science ®Google Scholar
• Cao S, Hu Y, Gao X, et al. Serum carbohydrate antigen 19–9 in differential diagnosis of benign and malignant pancreatic cystic neoplasms: a meta-analysis. PLoS One. 2016;11(11):e0166406. doi:10.1371/journal.pone.016640627835676
   PubMed Web of Science ®Google Scholar
• Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10(9):1199–1210. doi:10.1016/j.gassur.2006.08.01817114007
   PubMed Web of Science ®Google Scholar
• Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014;20(24):7864–7877. doi:10.3748/wjg.v20.i24.786424976723
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.116080919460998
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Kontomanolis E, Giatromanolaki A, et al. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol Obstet Invest. 2009;67(3):162–168. doi:10.1159/00018325019088479
   PubMed Web of Science ®Google Scholar
• Benboubker L, Valat C, Linassier C, et al. A new serologic index for low-grade non-Hodgkin’s lymphoma based on initial CA125 and LDH serum levels. Ann Oncol. 2000;11:1485–1491. doi:10.1023/A:102678923203311142490
   PubMed Web of Science ®Google Scholar
• Koh YW, Lee SJ, Park SY. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase. Pathol Res Pract. 2017;213:1134–1138. doi:10.1016/j.prp.2017.07.00628756978
   PubMed Web of Science ®Google Scholar
• Gan J, Wang W, Yang Z, et al. Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients: a meta-analysis of 18 observational studies. Medicine (Baltimore). 2018;97(46):e13151. doi:10.1097/MD.000000000001315130431587
   PubMed Web of Science ®Google Scholar
• Sonehara K, Tateishi K, Komatsu M, et al. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer. Thorac Cancer. 2020;11(6):1578–1586. doi:10.1111/1759-7714.1343232286017
   PubMed Web of Science ®Google Scholar
• Luo Y, Yang Z, Li D, et al. LDHB and FABP4 are associated with progression and poor prognosis of pancreatic ductal adenocarcinomas. Appl Immunohistochem Mol Morphol. 2017;25:351–357. doi:10.1097/PAI.000000000000030626657874
   PubMedGoogle Scholar
• Sun X, Sun Z, Zhu Z, et al. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer. Tumour Biol. 2015;36:7521–7530. doi:10.1007/s13277-015-3470-725913622
   PubMedGoogle Scholar
• Girgis H, Masui O, White NM, et al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer. 2014;13:101. doi:10.1186/1476-4598-13-10124885701
   PubMed Web of Science ®Google Scholar
• Yu C, Hou L, Cui H, et al. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma. Future Oncol. 2018;14:2483–2492. doi:10.2217/fon-2018-017729756998
   PubMed Web of Science ®Google Scholar
• Li SJ, Huang X, Xiao X, et al. Expression of LDHA in breast cancer and its clinical significance. J Chin Physician. 2017;19:207–209.
   Google Scholar
• Kamisawa T, Wood LD, Itoi T, et al. Pancreatic cancer. Lancet. 2016;388(10039):73–85. doi:10.1016/S0140-6736(16)00141-026830752
   PubMed Web of Science ®Google Scholar
• Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22:9694–9705. doi:10.3748/wjg.v22.i44.969427956793
   PubMed Web of Science ®Google Scholar
• Kim JE, Lee KT, Lee JK, et al. Clinical usefulness of carbohydrate antigen 19–9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol. 2004;19:182–186. doi:10.1111/j.1440-1746.2004.03219.x14731128
   PubMed Web of Science ®Google Scholar
• Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33:266–270. doi:10.1016/j.ejso.2006.10.00417097848
   PubMed Web of Science ®Google Scholar
• Chan A, Prassas I, Dimitromanolakis A, et al. Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. Clin Cancer Res. 2014;20:5787–5795. doi:10.1158/1078-0432.CCR-14-028925239611
   PubMed Web of Science ®Google Scholar
• Kaur S, Smith LM, Patel A, et al. A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study. Am J Gastroenterol. 2017;112(1):172–183. doi:10.1038/ajg.2016.48227845339
   PubMed Web of Science ®Google Scholar
• Balmaña M, Duran A, Gomes C, et al. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. Int J Biol Macromol. 2018;112(1):33–45. doi:10.1016/j.ijbiomac.2018.01.14829408556
   PubMed Web of Science ®Google Scholar
• Capurso G, Signoretti M, Valente R, et al. Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals. World J Gastrointest Endosc. 2015;7:833–842. doi:10.4253/wjge.v7.i9.83326240684
   PubMed Web of Science ®Google Scholar
• Le A, Cooper CR, Gouw AM, et al. Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA. 2010;107(5):2037–2042. doi:10.1073/pnas.091443310720133848
   PubMed Web of Science ®Google Scholar
• Jiang W, Zhou F, Li N, et al. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression. Int J Clin Exp Pathol. 2015;8:6756–6763.26261559
   PubMed Web of Science ®Google Scholar
• Jelski W, Chrostek L, Szmitkowski M. The activity of class I, II, III, and IV of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in pancreatic cancer. Pancreas. 2007;35(2):142–146. doi:10.1097/MPA.0b013e318053eae217632320
   PubMed Web of Science ®Google Scholar
• Jelski W, Zalewski B, Szmitkowski M. Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with pancreatic cancer. Dig Dis Sci. 2008;53(8):2276–2280. doi:10.1007/s10620-007-0144-318095160
   PubMed Web of Science ®Google Scholar
• Jelski W, Kutylowska E, Laniewska-Dunaj M, et al. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) as candidates for tumor markers in patients with pancreatic cancer. J Gastrointestin Liver Dis. 2011;20(3):255–259.21961092
   PubMed Web of Science ®Google Scholar